Semaglutide was initially only FDA-approved to help with blood sugar control in type 2 diabetes and to lower the risk of major cardiovascular events (like heart attack and stroke) in people with both type 2 diabetes and heart disease
Diets rich in vegetables, amino acids, antioxidants, and omega-3 fatty acids may reduce symptoms, while processed foods, artificial sugar, and caffeine may worsen them
Wellness clinics offering IV glutathione without individualized prescriptions operate in a regulatory gap the FDA monitors through warning letters but has not systematically shut down
In the 72-week study of more than 1,600 overweight or obese adults with Type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds, versus 2.2% for those who received a placebo, achieving the main goal of the trial
While much of the research remains in preclinical stages, early findings are promising